Insider trades

Mark C. Schneyer, CFO of Acadia Pharmaceuticals ACAD, has filed 0 purchases and 26 sales on the open market. Over the past 12 months that comes to a net sale of $538.8K. The latest trade was on 05/04.

Mark C. Schneyer

EVP, CFO
First filing
23/02/27
Trades
84 trades
Buys / sales
0 / 26
12-month net buying
−$538.8K
Last trade
05/04

Trading activity

Transactions

Trade type
Open-market sale05/0405/053,506 sh$21.79$76,395.74−5.0%
Open-market sale04/0704/072,709 sh$22.20$60,139.8−4.1%
ACAD
Open-market sale03/25–03/2603/267,385 sh3 trades$21.55avg.$159,135.98−10.9%
Open-market sale25/11/1825/11/1910,262 sh$23.69$243,106.78−16.1%
Open-market sale25/09/1525/09/163,498 sh$23.65$82,727.7−7.5%
Open-market sale10b5-1 plan25/08/1825/08/1922,000 sh$25.18$553,960−35.4%
Open-market sale10b5-1 plan25/05/1625/05/192,000 sh$25.00$50,000−3.1%
Open-market sale25/05/0225/05/023,498 sh$14.60$51,070.8−5.3%
Open-market sale25/04/0825/04/082,708 sh$14.82$40,132.56−4.4%
Open-market sale25/03/2625/03/263,171 sh$17.05$54,065.55−5.3%
Open-market sale25/02/2425/02/25773 sh$19.96$15,429.08−1.4%
Open-market sale24/11/1924/11/1910,259 sh$16.81$172,453.79−16.1%
Open-market sale24/08/1924/08/209,733 sh$15.28$148,720.24−18.2%
Open-market sale24/06/1024/06/11975 sh$14.79$14,420.25−2.7%
Open-market sale24/05/0224/05/033,503 sh$16.94$59,340.82−9.9%
Open-market sale24/04/0824/04/092,716 sh$17.87$48,534.92−8.6%
Open-market sale24/03/2724/03/275,434 sh$17.90$97,268.6−17.2%
Open-market sale24/02/2624/02/27772 sh$24.67$19,045.24−3.5%
Open-market sale23/11/2023/11/215,108 sh$22.64$115,645.12−20.0%
Open-market sale10b5-1 plan23/08/2123/08/2310,000 sh$29.00$290,000−38.9%